Open source biopharmaceutical innovation a mode of entry for firms in emerging markets

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of business chemistry
1. Verfasser: Allarakhia, Minna (VerfasserIn)
Format: UnknownFormat
Sprache:eng
Veröffentlicht: 2009
Schlagworte:
Schwellenländer > Pharmaindustrie > Arzneimittel > Internationaler Markteintritt > Innovationsmanagement > Wissensmanagement > Open Source > Aufsatz in Zeitschrift
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Titel Jahr Verfasser
Mergers & acquisitions (M&A) in the pharmaceutical industry : the wheel keeps on turning 2010 Hornke, Matthias
Knowledge sharing in heterogeneous collaborations - a longitudinal investigation of a cross-cultural research collaboration in nanoscience 2010 Kanzler, Steffen
Technological trajectories and multidimensional impacts: further remarks on the nanotechnology industry 2010
Nanotechnology patenting in China and Germany - a comparison of patent landscapes by bibliographic analyses 2010 Preschitschek, Nina
Bio products from bio refineries : trends, challenges and opportunities 2010 Vijayendran, Bhima
Analyzing the Direct Methanol Fuel Cell technology in portable applications by a historical and bibliometric analysis 2010 Suominen, Arho
Multidisciplinary collaborations in pharmaceutical innovation: a two case-study comparison 2010 Saur-Amaral, Irina
Pharma 3.0: delivering on health outcomes 2010 Flochel, Patrick
REACH implementation costs in the Belgian food industry : a semi-quantitative study 2010
Performance improvement in pharmaceutical R&D through new outsourcing models 2010 Festel, Gunter
Identifying the emerging roles of nanoparticles in biosensors 2010
New biocide active substances : needs and challenges in the EU as viewed by industry 2010 Kähkönen, Elina
Sustainability in the chemical and pharmaceutical industry : results of a benchmark analysis 2010 Peukert, Jürgen
The place of chemistry in business 2009 Little, Arthur D.
Open source biopharmaceutical innovation : a mode of entry for firms in emerging markets 2009 Allarakhia, Minna
Feasibility of Active Ingredient (AI) development for new biocides in the EU 2009
Chemists of the future 2009 Müllen, Klaus
Mergers & Acquisitions (M&A) in the pharmaceutical and chemical industries: a lighthouse in choppy waters 2009 Hornke, Matthias R.
REACH effects : opportunities and risks for transfer pricing 2009 Boller, Andreas
How to implement "access to medicine" and enhance economic performance : business model options for global access 2009 Peukert, Jürgen
Alle Artikel auflisten